Michael Vasconcelles
Chief Medical Officer, Cogent Biosciences, Inc.
Companies
- Day One Biopharmaceuticals, Inc.Head of Research and Dev. Jun 18, 2025 to now1
- Kura OncologyBoard member Sep 17, 2024 to now2
- ImmunoGen Inc.EVP R&D & MEDICAL AFFAIRS Jan 3, 2023 to Feb 12, 20243
- Magenta TherapeuticsBoard member Aug 17, 2022 to Aug 17, 20224
- Cogent Biosciences, Inc.Chief Medical Officer Mar 28, 2018 to Apr 11, 20195
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ImmunoGen Inc. IMGN0 shares6Feb 12, 2024
- Day One Biopharmaceuticals, Inc.0 shares7Apr 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 23, 2026Returned to company 4,397 shares of Day One Biopharmaceuticals, Inc.7
- Feb 17, 2026Sold 2,728 shares at $11.60 of Day One Biopharmaceuticals, Inc.8
- Feb 15, 2026Exercised options 7,125 shares of Day One Biopharmaceuticals, Inc.8
- Feb 12, 2024Returned to company 1,327 shares of ImmunoGen Inc.6
- Dec 29, 2023Granted 1,327 shares at $16.01 of ImmunoGen Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARKura Oncology, Board member
- 3
- 4SEC EDGARMagenta Therapeutics, Board member
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Feb 18, 2026
- 9SEC EDGARForm 4 filed Jan 3, 2024